TrialAntimicrobial agents and chemotherapy2023

Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study.

Sean T H Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.